43 results
S-1
EX-10.19
IKT
Inhibikase Therapeutics, Inc.
IPO registration
18 Jun 24
5:27pm
S-1
EX-10.20
IKT
Inhibikase Therapeutics, Inc.
IPO registration
18 Jun 24
5:27pm
8-K
EX-10.1
IKT
Inhibikase Therapeutics, Inc.
20 May 24
Inhibikase Therapeutics Announces Pricing of Registered Direct Offering and Warrant
8:55am
8-K
EX-10.2
IKT
Inhibikase Therapeutics, Inc.
20 May 24
Inhibikase Therapeutics Announces Pricing of Registered Direct Offering and Warrant
8:55am
8-K
EX-10.3
IKT
Inhibikase Therapeutics, Inc.
20 May 24
Inhibikase Therapeutics Announces Pricing of Registered Direct Offering and Warrant
8:55am
8-K
EX-10.1
3iifbx5f
1 Feb 24
Entry into a Material Definitive Agreement
4:09pm
8-K
EX-10.2
zp0zuerhi887795dxp
26 Jan 23
Inhibikase Therapeutics Announces $10 Million Concurrent Registered Direct Offering
4:02pm
8-K
EX-10.1
nte5zcbhqe60i1h1w9g
26 Jan 23
Inhibikase Therapeutics Announces $10 Million Concurrent Registered Direct Offering
4:02pm
8-K
EX-10.3
krn er8w9nash
26 Jan 23
Inhibikase Therapeutics Announces $10 Million Concurrent Registered Direct Offering
4:02pm
8-K
EX-10.1
b234m00
1 Sep 22
Inhibikase Therapeutics Appoints Gisele Dion to Board of Directors
5:30pm
8-K
EX-10.1
gqvxeyo
16 May 22
Entry into a Material Definitive Agreement
9:49pm
8-K
EX-10.3
wgyax53ici
8 Mar 22
Departure of Directors or Certain Officers
4:38pm
8-K
EX-10.2
sw6oz8 xo
8 Mar 22
Departure of Directors or Certain Officers
4:38pm
8-K
EX-10.1
g7aot
8 Mar 22
Departure of Directors or Certain Officers
4:38pm